The utility of cfDNA in TGCT patient management: a systematic review
Background: Testicular germ cell tumors (TGCTs) are the most common young male malignancy with a steadily rising incidence. Standard clinical practice is radical orchidectomy of suspicious lumps followed by histopathological diagnosis and tumor subtyping. This practice can lead to complications and...
Main Authors: | Jure Krasic, Lucija Skara, Ana Katusic Bojanac, Monika Ulamec, Davor Jezek, Tomislav Kulis, Nino Sincic |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-05-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359221090365 |
Similar Items
-
Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker
by: Lucija Škara, et al.
Published: (2023-01-01) -
Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source
by: Jure Krasic, et al.
Published: (2020-11-01) -
Erratum to “The utility of cfDNA in TGCT patient management: a systematic review”
Published: (2022-06-01) -
Epigenetically inactivated RASSF1A as a tumor biomarker
by: Dora Raos, et al.
Published: (2021-08-01) -
CNV Hotspots in Testicular Seminoma Tissue and Seminal Plasma
by: Dora Raos, et al.
Published: (2021-12-01)